BrightEdge is the innovation, impact investment and venture capital arm of the American Cancer Society. Today, our donor-funded ACS Impact Venture Fund (AIVF) invests in for-profit, early-stage companies developing cutting-edge, cancer-focused therapeutics, diagnostics, devices, and technologies to fuel and accelerate ACS’s mission of ending cancer as we know it, for everyone.
Company Details
- Employees
- 35
- Founded
- -
- Address
- Social Isolation And Other Critical Social Drivers Of Health While Improving Collaboration Between Healthcare
- Industry
- Venture Capital And Private Equity Principals
- NAICS
-
Miscellaneous Intermediation
- Website
- http://www.acsbrightedge.org
Brightedge - American Cancer Society Questions
Brightedge - American Cancer Society's website is http://www.acsbrightedge.org
Brightedge - American Cancer Society's LinkedIn profile is https://www.linkedin.com/company/brightedge-acs
Brightedge - American Cancer Society has
35 employees.
View email and phone details for 35
employees at Brightedge - American Cancer Society.
Brightedge - American Cancer Society's industry is
Venture Capital and Private Equity Principals
Brightedge - American Cancer Society's top competitors are
Foresite Capital,
Romero Capital,
Research Bridge Partners,
Epitet Therapeutics,
Catalio Capital Management,
August,
Modifi Bio,
American Cancer Society,
Mission-Driven Tech,
Brightedge.
Brightedge - American Cancer Society's categories are Venture Capital and Private Equity Principals
Brightedge - American Cancer Society's founding year is 2018
